These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3057833)

  • 1. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T; Kubo T; Akasaka T; Funyu T; Yagihashi Y; Kudo T; Tsuchida S; Harada T; Sasaki S; Orikasa S
    Hinyokika Kiyo; 1988 Aug; 34(8):1493-502. PubMed ID: 3057833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The phase IV studies with Estracyt in prostatic cancer--supplementary report: results of long-term therapy].
    Ohhori T; Kubo T; Kawamura S; Suzuki T; Yagihashi Y; Kudo T; Tsuchida S; Harada T; Sasaki S; Orikasa S
    Hinyokika Kiyo; 1992 Aug; 38(8):979-87. PubMed ID: 1414749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of estramustine phosphate disodium (Estracyt) on prostatic cancer--results of long-term therapy for 38 patients with prostatic cancer].
    Asakawa M; Wada S; Hayahara N; Yayumoto R; Kishimoto T; Maekawa M; Morikawa Y; Kawakita J; Umeda M; Horii A
    Hinyokika Kiyo; 1990 Nov; 36(11):1361-9. PubMed ID: 2288316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The evaluation of the effect of Estracyt on prostatic cancer].
    Fukuoka H; Ishibashi Y; Sakai N; Ogawa T; Satomi Y; Sugawara T; Kamimura H; Yamaguchi T; Kishida K; Shirai K
    Hinyokika Kiyo; 1991 Jan; 37(1):91-7. PubMed ID: 2011974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I
    Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estracyt therapy in advanced prostate cancer: current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 May; 22(3):162-6. PubMed ID: 6683899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative treatment with oral Estracyte in disseminated prostatic carcinoma.
    Welvaart K
    Arch Chir Neerl; 1975; 27(3):193-8. PubMed ID: 55103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of Estracyt in cases of prostatic neoplasms].
    Wesolowski S; Czaplicki M; Cieślak A
    Pol Przegl Chir; 1976 Jun; 48(6A):783-9. PubMed ID: 951325
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J; Catane R
    J Med; 1984; 15(1):35-43. PubMed ID: 6593404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stage D1 prostatic cancer benefited by a single regimen of Estracyt].
    Hata M
    Gan To Kagaku Ryoho; 1988 May; 15(5):1787-90. PubMed ID: 3369873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W; Wegner G
    Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 18. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.